Yazar "Çolak, E." için listeleme
-
The CYP 2C19*2 and CYP2C19*17 polymorphisms play a vital role in platelet responsiveness to clopidogrel after percutaneous coronary intervention: a pharmacogenomic study
Saydam, Faruk; Değirmenci, İrfan; Birdane, A.; Ozdemir, M.; Ulus, T.; Özbayer, Cansu; Çolak, E.; Ata, N.; Güneş, H.V. (Elsevier, 2015)Background: Clopidogrel inhibits platelet activation and aggregation by blocking the P2Y12 receptor. Dual antiplatelet therapy with clopidogrel and aspirin is recommended treatment by current guidelines for patients ... -
Determination of PKA values of some new triazole derivatives using different methods
Islamogiju, F.; Çolak, E.; Bal, E. (Syscom 18 SRL, 2013)The profanation constant values of 12 new triazole derivatives have been determined by potentiometric and spectrophotometric methods. Potentiometric and spectrophotometric methods were used in ethanol %50 - water %50, ...
